Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 25, 2023

Primary Completion Date

September 25, 2025

Study Completion Date

September 25, 2025

Conditions

RadiotherapyImmunotherapyLiver MetastasesColorectal Cancer

Interventions

RADIATION

SBRT

postoperative SBRT of liver lesions

DRUG

Chemotherapy

XELOX/FOLFOX/FOLFIRI

DRUG

PD-1 antibody

Sintilimab (200mg d1，q3w)

Trial Locations (1)

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors

lead

Fudan University

OTHER